ULK Antibodies

Santa Cruz Biotechnology features a diverse variety of ULK Antibodies for various research applications. Monoclonal ULK Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ULK, or Unc-51 Like Autophagy Activating Kinase, plays a central role in the regulation of autophagy, a vital cellular process for maintaining homeostasis and responding to stress. By initiating the formation of autophagosomes, ULK is essential for the degradation of damaged organelles and proteins, thereby contributing to cellular health and survival. Dysregulation of ULK has been implicated in various diseases, including cancer and neurodegenerative disorders, making it a significant target in both basic and translational research. Researchers worldwide utilize ULK monoclonal antibodies to advance their understanding of autophagy pathways and cellular mechanisms. The specificity and reliability of ULK monoclonal antibodies enable detailed investigation of autophagy regulation in various experimental models. Santa Cruz Biotechnology monoclonal ULK antibodies support researchers in their mission to uncover new insights into disease mechanisms and potential therapeutic strategies.